Infinity to Present At Upcoming Conferences
03 mars 2009 12h30 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 3, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will...
Infinity Announces Hedgehog Pathway Preclinical Data in Ovarian Cancer
09 févr. 2009 14h45 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 9, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the presentation of...
Infinity Announces Conference Call Discussing Fourth Quarter 2008 Results
02 févr. 2009 17h45 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 2, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Infinity management...
Infinity to Present At JP Morgan Healthcare Conference
06 janv. 2009 08h30 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 6, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman,...
Infinity Reacquires Worldwide Rights to Its Hsp90 Inhibitor Program
11 déc. 2008 06h00 HE
|
Infinity Pharmaceuticals, Inc.
Infinity to Independently Develop Its Industry-Leading Hsp90 Program
Clinical Programs Continue to Advance On Schedule
CAMBRIDGE, Mass., Dec. 11, 2008 (GLOBE NEWSWIRE) -- Infinity...
Infinity Announces Global Strategic Alliance With Purdue Pharma and Mundipharma Encompassing Infinity's Early Clinical and Discovery Programs
20 nov. 2008 06h00 HE
|
Infinity Pharmaceuticals, Inc.
Infinity Retains All U.S. Rights; Mundipharma Receives Ex-U.S.
Commercialization Rights to All Oncology Products Under Alliance
Infinity to Receive Up to $75 Million Equity...